Accipiter Biosciences Inc. — Form D

Accipiter Biosciences Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-28. The offering totals $13.7M, of which $7.9M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-05-28
• Form: D
• Accession: 0001973963-24-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $13.7M
• Amount sold: $7.9M
• Remaining: $5.8M
• Investors: 13
• Date of first sale: 2024-05-17
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-514316

Issuer

• Name: Accipiter Biosciences Inc.
• CIK: 0001973963
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 1616 EASTLAKE AVE E. SUITE 208, SEATTLE, WA, 98102
• Phone: 212-472-6343

Officers, directors & promoters (24)

Other filings by this issuer (3)

More

• CIK 1973963 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search